Acellmed Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Acellmed Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)

Secondary Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing | Navigational, Measuring, Electromedical, and Control Instruments Manufacturing | Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Professional, Scientific, and Technical Services | Ambulatory Health Care Services

Full name: Acellmed Sp. z o.o.

Profile Updated: May 08, 2024

Acellmed Sp. z o.o. is an enterprise located in Poland, with the main office in Zabrze. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on August 22, 2019. The latest financial highlights indicate a net sales revenue drop of 50.52% in 2022. There was a total growth of 0.34% in Acellmed Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Marii Curie-Sklodowskiej 10C
Zabrze; Slaskie; Postal Code: 41-800

Contact Details: Purchase the Acellmed Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Acellmed Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Acellmed Sp. z o.o. report to view the information.

Incorporation Date:

August 22, 2019

Key Executives

Purchase this report to view the information.

Vice President

Ownership Details

Purchase this report to view the information.

100%

Company Performance

Financial values in the chart are available after Acellmed Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

-50.52%▼

Total operating revenue

-50.51%▼

Operating profit (EBIT)

N/A

Net Profit (Loss) for the Period

N/A

Total assets

0.34%▲

Total equity

-37.68%▼

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A